61/100B51.365
USD
-0.33
(-0.64%)
Market Closed
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Q4 FY2026 · Earnings report
EPS estimate 0.23Revenue estimate 1.25B
Genmab A current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
Genmab A/S ADS's current ratio is 2.45: current assets of 3.19B USD against current liabilities of 1.30B USD due within a year.
- Today
- 2.45
- Average, 5 years
- 8.98
- Low, 5 years
- 2.02
- High, 5 years
- 17.31
Current ratio = current assets ÷ current liabilities = 3.19B ÷ 1.30B = 2.45
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 2.45 | 3.19B | 1.30B | |
| FY2025 | 31 Dec 2025 | 2.02 | 2.88B | 1.42B |
| FY2024 | 31 Dec 2024 | 5.25 | 27.85B | 5.31B |
| FY2023 | 31 Dec 2023 | 13.34 | 33.14B | 2.48B |
| FY2022 | 31 Dec 2022 | 15.48 | 28.22B | 1.82B |
| FY2021 | 31 Dec 2021 | 14.50 | 22.74B | 1.57B |
| FY2020 | 31 Dec 2020 | 15.00 | 18.79B | 1.25B |
| FY2019 | 31 Dec 2019 | 14.88 | 13.96B | 938.00M |
| FY2018 | 31 Dec 2018 | 16.77 | 7.43B | 443.35M |
| FY2017 | 31 Dec 2017 | 18.52 | 6.06B | 327.12M |
| FY2016 | 31 Dec 2016 | 11.90 | 4.90B | 411.54M |
| FY2015 | 31 Dec 2015 | 8.85 | 3.67B | 414.40M |
| FY2014 | 31 Dec 2014 | 4.22 | 2.77B | 655.97M |
| FY2013 | 31 Dec 2013 | 1.87 | 1.69B | 907.50M |
| FY2012 | 31 Dec 2012 | 1.40 | 1.65B | 1.18B |
| FY2011 | 31 Dec 2011 | 1.55 | 1.52B | 976.73M |
| FY2010 | 31 Dec 2010 | 1.83 | 2.42B | 1.32B |
| FY2009 | 31 Dec 2009 | 2.41 | 2.16B | 894.34M |
| FY2008 | 31 Dec 2008 | 1.85 | 1.97B | 1.06B |
| FY2007 | 31 Dec 2007 | 3.67 | 3.92B | 1.07B |
| FY2006 | 31 Dec 2006 | 9.53 | 1.77B | 185.80M |
| FY2005 | 31 Dec 2005 | 5.58 | 1.32B | 237.18M |
| FY2004 | 31 Dec 2004 | 17.04 | 1.19B | 69.96M |
| FY2003 | 31 Dec 2003 | 14.21 | 1.07B | 75.11M |
| FY2002 | 31 Dec 2002 | 8.84 | 1.42B | 160.40M |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 2.45 | 3.19B | 1.30B |
| Q2 FY2026 | 30 Jun 2026 | 2.46 | 2.80B | 1.14B |
| Q1 FY2026 | 31 Mar 2026 | 2.18 | 2.57B | 1.18B |
| Q4 FY2025 | 31 Dec 2025 | 2.02 | 2.88B | 1.42B |
| Q3 FY2025 | 30 Sept 2025 | 6.03 | 4.47B | 741.00M |
| Q2 FY2025 | 30 Jun 2025 | 6.22 | 3.91B | 628.87M |
| Q1 FY2025 | 31 Mar 2025 | 6.22 | 3.65B | 586.66M |
| Q4 FY2024 | 31 Dec 2024 | 5.25 | 27.85B | 5.31B |
| Q3 FY2024 | 30 Sept 2024 | 5.17 | 23.70B | 4.59B |
| Q2 FY2024 | 30 Jun 2024 | 5.03 | 21.94B | 4.36B |
| Q1 FY2024 | 31 Mar 2024 | 12.46 | 34.37B | 2.76B |
| Q4 FY2023 | 31 Dec 2023 | 13.34 | 33.14B | 2.48B |
| Q3 FY2023 | 30 Sept 2023 | 11.38 | 33.03B | 2.90B |
| Q2 FY2023 | 30 Jun 2023 | 14.93 | 29.75B | 1.99B |
| Q1 FY2023 | 31 Mar 2023 | 14.44 | 28.23B | 1.96B |
| Q4 FY2022 | 31 Dec 2022 | 15.48 | 28.22B | 1.82B |
| Q3 FY2022 | 30 Sept 2022 | 9.62 | 28.74B | 2.99B |
| Q2 FY2022 | 30 Jun 2022 | 13.11 | 25.49B | 1.94B |
| Q1 FY2022 | 31 Mar 2022 | 17.31 | 23.18B | 1.34B |
| Q4 FY2021 | 31 Dec 2021 | 14.50 | 22.74B | 1.57B |
| Q3 FY2021 | 30 Sept 2021 | 12.00 | 21.95B | 1.83B |
| Q2 FY2021 | 30 Jun 2021 | 15.03 | 20.30B | 1.35B |
| Q1 FY2021 | 31 Mar 2021 | 15.42 | 19.94B | 1.29B |
| Q4 FY2020 | 31 Dec 2020 | 15.00 | 18.79B | 1.25B |
| Q3 FY2020 | 30 Sept 2020 | 8.64 | 19.50B | 2.26B |
| Q2 FY2020 | 30 Jun 2020 | 9.53 | 19.14B | 2.01B |
| Q1 FY2020 | 31 Mar 2020 | 19.04 | 2.07B | 108.81M |
| Q4 FY2019 | 31 Dec 2019 | 14.88 | 13.96B | 938.00M |
| Q3 FY2019 | 30 Sept 2019 | 18.72 | 12.26B | 654.77M |
| Q2 FY2019 | 30 Jun 2019 | 14.89 | 7.81B | 524.56M |
| Q1 FY2019 | 31 Mar 2019 | 17.30 | 7.54B | 435.70M |
| Q4 FY2018 | 31 Dec 2018 | 16.77 | 7.43B | 443.35M |
| Q3 FY2018 | 30 Sept 2018 | 20.47 | 6.57B | 321.13M |
| Q2 FY2018 | 30 Jun 2018 | 19.94 | 6.68B | 334.86M |
| Q1 FY2018 | 31 Mar 2018 | 23.99 | 6.22B | 259.30M |
| Q4 FY2017 | 31 Dec 2017 | 18.52 | 6.06B | 327.12M |
| Q3 FY2017 | 30 Sept 2017 | 13.04 | 5.57B | 426.79M |
| Q2 FY2017 | 30 Jun 2017 | 9.71 | 5.72B | 589.16M |
| Q1 FY2017 | 31 Mar 2017 | 12.71 | 5.08B | 399.38M |
| Q4 FY2016 | 31 Dec 2016 | 11.90 | 4.90B | 411.54M |
| Q3 FY2016 | 30 Sept 2016 | 9.89 | 4.14B | 418.94M |
| Q2 FY2016 | 30 Jun 2016 | 10.33 | 3.91B | 378.22M |
| Q1 FY2016 | 31 Mar 2016 | 9.48 | 3.68B | 388.45M |
| Q4 FY2015 | 31 Dec 2015 | 8.85 | 3.67B | 414.40M |
| Q3 FY2015 | 30 Sept 2015 | 7.12 | 3.28B | 460.53M |
| Q2 FY2015 | 30 Jun 2015 | 5.96 | 3.05B | 512.71M |
| Q1 FY2015 | 31 Mar 2015 | 5.18 | 3.03B | 585.61M |
| Q4 FY2014 | 31 Dec 2014 | 4.22 | 2.77B | 655.97M |
| Q3 FY2014 | 30 Sept 2014 | 3.79 | 2.73B | 719.40M |
| Q2 FY2014 | 30 Jun 2014 | 3.37 | 2.68B | 795.52M |
| Q1 FY2014 | 31 Mar 2014 | 3.19 | 2.75B | 861.56M |
| Q4 FY2013 | 31 Dec 2013 | 1.87 | 1.69B | 907.50M |
| Q3 FY2013 | 30 Sept 2013 | 1.52 | 1.76B | 1.16B |
| Q2 FY2013 | 30 Jun 2013 | 1.56 | 1.64B | 1.06B |
| Q1 FY2013 | 31 Mar 2013 | 1.50 | 1.72B | 1.14B |
| Q4 FY2012 | 31 Dec 2012 | 1.40 | 1.65B | 1.18B |
| Q3 FY2012 | 30 Sept 2012 | 1.30 | 1.73B | 1.33B |
| Q2 FY2012 | 30 Jun 2012 | 1.48 | 1.38B | 927.77M |
| Q1 FY2012 | 31 Mar 2012 | 1.51 | 1.42B | 935.59M |
| Q4 FY2011 | 31 Dec 2011 | 1.55 | 1.52B | 976.73M |
| Q3 FY2011 | 30 Sept 2011 | 1.51 | 1.62B | 1.07B |
| Q2 FY2011 | 30 Jun 2011 | 1.80 | 2.00B | 1.11B |
| Q1 FY2011 | 31 Mar 2011 | 1.82 | 2.14B | 1.17B |
| Q4 FY2010 | 31 Dec 2010 | 1.83 | 2.42B | 1.32B |
| Q3 FY2010 | 30 Sept 2010 | 1.88 | 2.40B | 1.27B |
| Q2 FY2010 | 30 Jun 2010 | 2.67 | 1.89B | 707.88M |
| Q1 FY2010 | 31 Mar 2010 | 2.40 | 2.02B | 840.83M |
| Q4 FY2009 | 31 Dec 2009 | 2.41 | 2.16B | 894.34M |
| Q3 FY2009 | 30 Sept 2009 | — | — | — |
| Q2 FY2009 | 30 Jun 2009 | — | — | — |
| Q1 FY2009 | 31 Mar 2009 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Debt to equity,All ratios
Common questions about Genmab A's current ratio
Source: Financial Modeling Prep